Internal Medicine, Hematology & Oncology · South San Francisco, CA
NPI
1235281452
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 El Camino Real
South San Francisco, CA, 94080
Phone (650) 742-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.1M
893 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Supriya Rajpal prescribed most often to Medicare patients was Anastrozole, with 223 prescriptions and refills. In total Supriya Rajpal wrote 893 Medicare prescriptions that cost $3.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 223 | 659 | 76 | $6,162 |
| Kisqali Ribociclib Succinate | 52 | 52 | Under 11 | $709K |
| Verzenio Abemaciclib | 46 | 46 | Under 11 | $622K |
| Letrozole Generic | 45 | 111 | 13 | $1,206 |
| Ondansetron Hcl Generic | 41 | 41 | 21 | $342 |
| Exemestane Generic | 36 | 72 | 12 | $2,131 |
| Dexamethasone Generic | 30 | 30 | 14 | $412 |
| Prochlorperazine Maleate Generic | 26 | 26 | 13 | $371 |
| Granisetron Hcl Generic | 24 | 27 | Under 11 | $1,274 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $344 |
| Ibrance Palbociclib | 20 | 20 | Under 11 | $308K |
| Alendronate Sodium Generic | 19 | 51 | Under 11 | $183 |
| Granix Tbo-Filgrastim | 17 | 17 | Under 11 | $11K |
| Hydroxyurea Generic | 17 | 40 | Under 11 | $604 |
| Piqray Alpelisib | 17 | 18 | Under 11 | $403K |
Brand drugs: 235 claims; generic drugs: 658 claims; opioid claims: 51.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Supriya Rajpal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.